CAMP — CAMP4 Therapeutics Share News
0.000.00%
Last trade - 00:00- $207.09m
- $120.69m
- $3.50m
Camp4 Therapeutics Corp Reports Results For The Quarter Ended June 30: Earnings Summary
Camp4 Therapeutics Q2 Loss Per Share Misses Estimates On Non: cash derivative charge
Camp4 Therapeutics Corp Expected To Post A Loss Of 21 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation
U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle
CAMP4 Therapeutics Q1 profit misses estimates, net loss widens
Brief: Camp4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM
NASDAQ RESUMED AT 12:43 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:38 PM
CAMP4 Therapeutics misses 2025 EPS expectations
U.S. STOCKS ON THE MOVE-Cintas, Jabil, Eli Lilly
U.S. STOCKS ON THE MOVE-Accenture, Darden Restaurants, Howard Hughes
CAMP4 Therapeutics drops after $30 mln stock sale, GSK deal
Brief: Camp4 Therapeutics - Under Deal With GSK, Eligible For Up To $440 Million In Milestone Payments
Brief: CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Camp4 Therapeutics to Offer Up To $300 Million In Securities - SEC Filing
Brief: Camp4 Therapeutics Initiates GLP Toxicology Studies For Cmp-Syngap-01
U.S. RESEARCH ROUNDUP- aTyr pharma, Clear Secure, Neumora Therapeutics